Answers are grounded in this paper and cite their sources.
High glycemic variability (GV) is a biomarker of cancer risk, even in the absence of diabetes. The emerging concept of chrononutrition suggests that modifying meal timing can favorably impact metabolic risk factors linked to diet-related chronic disease, including breast cancer. Here, we examined the potential of eating when glucose levels are near personalized fasting thresholds (low-glucose eating, LGE), a novel form of timed-eating, to reduce GV in women without diabetes, who are at risk for postmenopausal breast cancer.
No takes yet. Share an insight, caveat, or question.
Jospe et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: